This inventor holds 1 USPTO granted patent. Top assignees: Nippon Steel Chemical Co., Ltd., Nippon Steel Corporation. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 173 
1 out of 3,713 Years Active: 1999
Title: Takeo Okazaki: Innovator in Pharmaceutical Chemistry
Introduction
Takeo Okazaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fibrinogen receptor antagonists.
Latest Patents
Takeo Okazaki holds 1 patent for his invention titled "Fibrinogen receptor antagonist and pharmaceutical compositions." This patent includes compounds of a specific general formula and pharmaceutically acceptable salts thereof, showcasing his expertise in developing new therapeutic agents.
Career Highlights
Throughout his career, Okazaki has worked with prominent companies such as Nippon Steel Corporation and Nippon Steel Chemical Co., Ltd. His experience in these organizations has allowed him to apply his knowledge and skills in a practical setting, contributing to advancements in pharmaceutical research.
Collaborations
Okazaki has collaborated with esteemed colleagues, including Tohru Asari and Yoshimi Satoh. These partnerships have further enriched his work and expanded the impact of his inventions in the industry.
Conclusion
Takeo Okazaki's contributions to pharmaceutical chemistry, particularly through his patent on fibrinogen receptor antagonists, highlight his role as an innovator in the field. His collaborations and career experiences reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile